Market Place
Sourcing Support
Alembic Pharma gets tentative USFDA nod for Olopatadine drug
04 Dec 2024 //
BUSINESS STD
Glenmark arm recalls products in US for manufacturing issues
13 Oct 2024 //
ECONOMICTIMES
Enforcement Report - Week of October 9, 2024
09 Oct 2024 //
FDA
Glenmark Launches OTC Olopatadine Hydrochloride Ophthalmic Solution
19 Aug 2024 //
PR NEWSWIRE
Glenmark Therapeutics launches Olopatadine Hydrochloride Ophthalmic Solution USP
19 Aug 2024 //
INDIANPHARMAPOST
Lupin Pharm`s Generic Olopatadine HCL Receives Tentative Approval in US
26 Jun 2024 //
FDA
Enforcement Report - Week of June 7, 2023
07 Jun 2023 //
FDA
Enforcement Report - Week of March 22, 2023
22 Mar 2023 //
FDA
Enforcement Report - Week of January 25, 2023
25 Jan 2023 //
FDA
Health Canada approves Bausch Health-Glenmark’s allergic rhinitis treatment
26 Sep 2022 //
PHARMACEUTICAL-TECHNOLOGY
Health Canada approves Ryaltris for treatment of Seasonal Allergic Rhinitis
26 Sep 2022 //
EXPRESS PHARMA
Glenmark`s partner Hikma launches specialty drug Ryaltris in US
30 Aug 2022 //
ECONOMICTIMES
Hikma launches RYALTRIS seasonal allergic rhinitis nasal spray in the US
30 Aug 2022 //
PRNEWSWIRE
Enforcement Report - Week of August 17, 2022
17 Aug 2022 //
FDA
Enforcement Report - Week of July 6, 2022
06 Jul 2022 //
FDA
Glenmark receives marketing approval for Ryaltris in 13 countries across EU, UK
30 Sep 2021 //
ANINEWS
Glenmark’s Ryaltris nasal spray approved in Europe to treat allergic rhinitis
26 Apr 2021 //
PHARMABIZ
Glenmark arm gets Russian health ministry nod for nasal spray Ryaltris
22 Feb 2021 //
INDIATIMES
Gland Pharma`s Generic Olopatadine Hydrochloride Receives Approval In US
07 Nov 2020 //
FDA
Dr Reddy`s Laboratories launches over-the-counter eye allergy drop in US
16 Sep 2020 //
ECONOMICTIMES
Dr. Reddy launches Over-theCounter Olopatadine Hydrochloride Ophthalmic Solution
16 Sep 2020 //
BUSINESSWIRE
Hikma & Glenmark Enter into Exclusive Licensing Agreement for Ryaltris™
27 Feb 2020 //
PR NEWSWIRE
Hikma Pharma to commercialise Glenmark Pharma’s new nasal spray Ryaltris in US
26 Feb 2020 //
PHARMABIZ
Rx-to-OTC Switches: FDA Signs Off on Three Drugs
17 Feb 2020 //
RAPS
Glenmark gets approval from Australian regulator to commercialise Ryaltris
20 Dec 2019 //
BUSINESS STANDARD
Gland Pharma`s Generic Olopatadine Hydrochloride Receives Approval in US
14 Aug 2019 //
FDA
Gland Pharma`s Generic Olopatadine Hydrochloride Receives Approval in US
09 Aug 2019 //
FDA
Glenmark has wind knocked out of NDA for respiratory drug by FDA
25 Jun 2019 //
FIERCE PHARMA
Alembic Pharmaceuticals gets USFDA nod for ophthalmic solution
15 Feb 2019 //
ECONOMIC TIMES
Glenmark Pharma signs an agreement with Grandpharma
06 Feb 2019 //
BIOSPECTRUM ASIA
Glenmark in second licensing deal for anti-histamine
10 Jan 2019 //
PRESS RELEASE
Apotex`s Generic Olopatadine Hydrochloride Receives Tentative Approval in US
10 Jan 2019 //
FDA
Alembic Pharmaceuticals gets USFDA nod for ophthalmic solution
10 Dec 2018 //
ECONOMIC TIMES
FTC Approves Merger of Generic Drug Marketers Amneal, Impax
11 Jul 2018 //
FTC GOV
Glenmark Pharma inks pact with Seqirus
06 Jul 2018 //
HINDU BUSINESS LINE
Cipla’s Generic Olopatadine Hydrochloride Receives Approval In US
09 Dec 2017 //
FDA
Apotex’s Generic Olopatadine Hydrochloride Receives Approval In US
07 Dec 2017 //
FDA
Cipla’s Generic Olopatadine Hydrochloride Receives Tentative Approval In US
03 Jul 2017 //
FDA
Wockhardt’s Generic Olopatadine Hydrochloride Receives Approval In US
30 Jun 2017 //
FDA
Akorn’s Generic Olopatadine Hydrochloride Receives Approval In US
10 Jan 2017 //
FDA
Argentum and Alcon Settle Patent Dispute Over PAZEO®
30 Nov 2016 //
PR NEWSWIRE
Akorn Inc Generic Olopatadine Hydrochloride Approved In US
23 Sep 2016 //
FDA
No quick fix seen for Novartis`s troubled Alcon unit
11 Jan 2016 //
REUTERS
New US approvals to boost Aurobindo
28 Dec 2015 //
BUSINESS STANDARD
Strides Shasun gets DCGI nod to manufacture Hepatitis C drug
21 Dec 2015 //
BUSINESS STANDARD
